MYB exhibits racially disparate expression, clinicopathologic association, and predictive potential for biochemical recurrence in prostate cancer.

Khan, Mohammad Aslam; Acharya, Srijan; Anand, Shashi; Sameeta, Fnu; Pramanik, Paramahansa; Keel, Christopher; Singh, Seema; Carter, James Elliot; Dasgupta, Santanu; Singh, Ajay Pratap.

Afiliação

Khan MA; Department of Pathology, College of Medicine, University of South Alabama, Mobile, AL 36617, USA.
Acharya S; Cancer Biology Program, Mitchell Cancer Institute, University of South Alabama, Mobile, AL 36604, USA.
Anand S; Department of Pathology, College of Medicine, University of South Alabama, Mobile, AL 36617, USA.
Sameeta F; Cancer Biology Program, Mitchell Cancer Institute, University of South Alabama, Mobile, AL 36604, USA.
Pramanik P; Department of Pathology, College of Medicine, University of South Alabama, Mobile, AL 36617, USA.
Keel C; Cancer Biology Program, Mitchell Cancer Institute, University of South Alabama, Mobile, AL 36604, USA.
Singh S; Department of Pathology, College of Medicine, University of South Alabama, Mobile, AL 36617, USA.
Carter JE; Department of Mathematics and Statistics, University of South Alabama, Mobile, AL 36688, USA.
Dasgupta S; Department of Urology, Frederick P. Whiddon College of Medicine, University of South Alabama, Mobile, AL 36688, USA.
Singh AP; Department of Pathology, College of Medicine, University of South Alabama, Mobile, AL 36617, USA.